<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1545">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05141045</url>
  </required_header>
  <id_info>
    <org_study_id>1708288-3</org_study_id>
    <nct_id>NCT05141045</nct_id>
  </id_info>
  <brief_title>The Effect of Fish Oil Supplementation on Vocal Performance</brief_title>
  <official_title>The Effect of Fish Oil Supplementation on Vocal Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to determine if use of omega-3 PUFA supplement in combination&#xD;
      with a singer's training regimen enhances training adaptations and body composition.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 8, 2021</start_date>
  <completion_date type="Actual">May 13, 2021</completion_date>
  <primary_completion_date type="Actual">May 13, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Evaluation of Ability to Sing Easily</measure>
    <time_frame>baseline and up to 11 weeks</time_frame>
    <description>survey designed to aid in subject self-assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in Voice Range Profile</measure>
    <time_frame>baseline and up to 11 weeks</time_frame>
    <description>known as a phonetogram, is a representation of a participants minimum and maximum intensity levels across vocal range</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Body composition</measure>
    <time_frame>baseline and up to 11 weeks</time_frame>
    <description>height in cm, weight measured in kg. Bio-electrical impedance scale use to assess lean and body fat mass, measured in kg. Weight and height were combined to report BMI in kg/m^2</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Voice Range Profile</condition>
  <condition>Reflux Symptom Index</condition>
  <condition>Evaluation of Ability to Sing Easily</condition>
  <condition>Body Composition</condition>
  <arm_group>
    <arm_group_label>omega-3 PUFA supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>omega-3 PUFA supplement, 3.0 grams per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>safflower oil, 3.0 grams per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>omega-3 PUFA supplement</intervention_name>
    <description>participants were instructed to take 3.0 grams per day of omega-3 PUFA supplement</description>
    <arm_group_label>omega-3 PUFA supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Apparently healthy college vocal performers (male and female of all ethnicities)&#xD;
             *Between the ages of 18-28 years&#xD;
&#xD;
          -  Majoring in classical voice in the Baylor University School of Music or musical&#xD;
             theatre in the Baylor University Department of Theatre Arts.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previously diagnosed with a voice disorder&#xD;
&#xD;
          -  Vegans&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Allergic to fish, shellfish or safflower oil&#xD;
&#xD;
          -  Have been taking daily FO n-3 supplement within the past three months, or any&#xD;
             supplement known to effect muscle biology (e.g. creatine).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LesLee Funderburk, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baylor University</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76798</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 17, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

